Phase I Dose Escalation Study Of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in FIGO IB2 and Bulky IIA Cervical Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Paclitaxel
- Indications Cervical cancer
- Focus Adverse reactions
Most Recent Events
- 06 Jan 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 Jan 2010 Biomarkers information updated
- 22 Jan 2009 New trial record.